A thorough analysis of HLA-type together with experiments testing HLA-presentation with donor-matched LMP1 sequences would be necessary to conclude if polymorphisms that are conserved in NPC tumors are selected for immune evasion properties. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.